| Lastest Insider Transactions Of Intra-Cellular Therapies, Inc. ( ITCI ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ITCI | Intra-Cellular Therapies, Inc. | Satlin Andrew | EVP and Chief Medical Officer | 2020-01-08 | Sell | 11,573 | 26.16 | 302,750 | 2020-01-10 21:14:33 |
| ITCI | Intra-Cellular Therapies, Inc. | Satlin Andrew | EVP and Chief Medical Officer | 2020-01-08 | Option Exercise | 22,911 | 0.00 | 0 | 2020-01-10 21:14:33 |
| ITCI | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | 2020-01-08 | Option Exercise | 20,947 | 0.00 | 0 | 2020-01-10 21:11:16 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2020-01-09 | Sell | 41,895 | 26.16 | 1,095,973 | 2020-01-10 21:09:01 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2020-01-09 | Sell | 19,638 | 26.16 | 513,730 | 2020-01-10 21:06:55 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2020-01-09 | Sell | 19,638 | 26.16 | 513,730 | 2020-01-10 21:03:50 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2020-01-06 | Sell | 45,598 | 30.28 | 1,380,880 | 2020-01-08 21:11:17 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2020-01-06 | Option Exercise | 101,895 | 1.61 | 164,400 | 2020-01-08 21:11:17 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2020-01-06 | Sell | 21,458 | 30.34 | 651,007 | 2020-01-08 21:02:01 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2020-01-06 | Option Exercise | 19,638 | 0.00 | 0 | 2020-01-08 21:02:01 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2020-01-06 | Sell | 21,458 | 30.29 | 650,003 | 2020-01-08 21:00:40 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2020-01-06 | Option Exercise | 19,638 | 0.00 | 0 | 2020-01-08 21:00:40 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2019-12-31 | Sell | 7,807 | 32.43 | 253,214 | 2020-01-03 21:17:22 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2019-12-31 | Option Exercise | 21,458 | 0.00 | 0 | 2020-01-03 21:17:22 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2019-12-31 | Sell | 7,807 | 32.43 | 253,165 | 2020-01-03 21:16:01 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2019-12-31 | Option Exercise | 21,458 | 0.00 | 0 | 2020-01-03 21:16:01 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2019-12-31 | Sell | 17,478 | 32.45 | 567,230 | 2020-01-03 21:14:41 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2019-12-31 | Option Exercise | 51,598 | 0.32 | 16,440 | 2020-01-03 21:14:41 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2019-12-23 | Sell | 15,032 | 25.50 | 383,316 | 2019-12-26 16:06:34 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2019-12-23 | Option Exercise | 9,600 | 2.74 | 26,304 | 2019-12-26 16:06:34 |
| ITCI | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | 2019-10-15 | Sell | 6,774 | 8.25 | 55,886 | 2019-10-17 16:50:05 |
| ITCI | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | 2019-10-15 | Option Exercise | 13,448 | 0.00 | 0 | 2019-10-17 16:50:05 |
| ITCI | Intra-Cellular Therapies, Inc. | Alafi Christopher D | Directior 10% Owner | 2019-09-10 | Buy | 485,000 | 10.26 | 4,974,678 | 2019-09-11 16:30:49 |
| ITCI | Intra-Cellular Therapies, Inc. | Alafi Christopher D | Directior | 2019-08-30 | Buy | 125,000 | 8.52 | 1,065,213 | 2019-09-04 18:24:08 |
| ITCI | Intra-Cellular Therapies, Inc. | Alafi Christopher D | Directior | 2017-11-22 | Buy | 10,000 | 15.55 | 155,500 | 2019-06-19 17:48:33 |
| ITCI | Intra-Cellular Therapies, Inc. | Alafi Christopher D | Directior | 2019-06-12 | Buy | 170,000 | 11.73 | 1,993,793 | 2019-06-14 17:23:38 |
| ITCI | Intra-Cellular Therapies, Inc. | MARCUS JOEL S | Directior | 2019-05-29 | Option Exercise | 20,000 | 12.45 | 249,000 | 2019-05-31 16:35:24 |
| ITCI | Intra-Cellular Therapies, Inc. | Alafi Christopher D | Directior | 2019-05-14 | Buy | 100,000 | 12.56 | 1,256,350 | 2019-05-15 18:03:50 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2019-02-27 | Sell | 1,000 | 15.00 | 15,000 | 2019-03-01 19:41:12 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2019-02-27 | Option Exercise | 10,400 | 2.74 | 28,496 | 2019-03-01 19:41:12 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2019-01-04 | Sell | 52,202 | 11.58 | 604,310 | 2019-01-08 21:28:12 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2019-01-04 | Option Exercise | 6,604 | 0.00 | 0 | 2019-01-08 21:28:12 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2019-01-04 | Sell | 24,566 | 11.58 | 284,418 | 2019-01-08 21:24:26 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2019-01-04 | Option Exercise | 3,108 | 0.00 | 0 | 2019-01-08 21:24:26 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2019-01-04 | Sell | 24,566 | 11.58 | 284,383 | 2019-01-08 21:21:59 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2019-01-04 | Option Exercise | 3,108 | 0.00 | 0 | 2019-01-08 21:21:59 |
| ITCI | Intra-Cellular Therapies, Inc. | Vanover Kimberly E. | SVP, Early Stage Clinical Dev. | 2019-01-04 | Sell | 10,156 | 11.52 | 116,979 | 2019-01-08 21:19:21 |
| ITCI | Intra-Cellular Therapies, Inc. | Vanover Kimberly E. | SVP, Early Stage Clinical Dev. | 2019-01-04 | Option Exercise | 1,554 | 0.00 | 0 | 2019-01-08 21:19:21 |
| ITCI | Intra-Cellular Therapies, Inc. | Davis Robert E | SVP, Chief Scientific Officer | 2019-01-04 | Sell | 9,564 | 11.46 | 109,630 | 2019-01-08 21:16:12 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2018-12-31 | Sell | 17,478 | 11.09 | 193,831 | 2019-01-03 21:02:05 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2018-12-31 | Option Exercise | 45,598 | 0.00 | 0 | 2019-01-03 21:02:05 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2018-12-31 | Sell | 7,807 | 11.09 | 86,580 | 2019-01-03 20:58:52 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2018-12-31 | Option Exercise | 21,458 | 0.00 | 0 | 2019-01-03 20:58:52 |
| ITCI | Intra-Cellular Therapies, Inc. | Vanover Kimberly E. | SVP, Early Stage Clinical Dev. | 2018-12-31 | Sell | 4,834 | 11.10 | 53,657 | 2019-01-03 20:46:21 |
| ITCI | Intra-Cellular Therapies, Inc. | Vanover Kimberly E. | SVP, Early Stage Clinical Dev. | 2018-12-31 | Option Exercise | 18,809 | 0.00 | 0 | 2019-01-03 20:46:21 |
| ITCI | Intra-Cellular Therapies, Inc. | Davis Robert E | SVP, Chief Scientific Officer | 2018-12-31 | Sell | 4,834 | 11.11 | 53,706 | 2019-01-03 20:42:28 |
| ITCI | Intra-Cellular Therapies, Inc. | Davis Robert E | SVP, Chief Scientific Officer | 2018-12-31 | Option Exercise | 18,809 | 0.00 | 0 | 2019-01-03 20:42:28 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2018-12-31 | Sell | 7,807 | 11.09 | 86,580 | 2019-01-03 20:23:25 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2018-12-31 | Option Exercise | 21,458 | 0.00 | 0 | 2019-01-03 20:23:25 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2018-12-10 | Option Exercise | 50,000 | 1.50 | 75,000 | 2018-12-11 17:55:31 |
| ITCI | Intra-Cellular Therapies, Inc. | Davis Robert E | SVP, Chief Scientific Officer | 2018-12-04 | Sell | 899 | 13.53 | 12,163 | 2018-12-07 16:44:04 |
| ITCI | Intra-Cellular Therapies, Inc. | Davis Robert E | SVP, Chief Scientific Officer | 2018-12-04 | Option Exercise | 1,758 | 0.00 | 0 | 2018-12-07 16:44:04 |
| ITCI | Intra-Cellular Therapies, Inc. | MARCUS JOEL S | Directior | 2018-11-09 | Sell | 32,000 | 18.17 | 581,580 | 2018-11-13 17:34:49 |
| ITCI | Intra-Cellular Therapies, Inc. | LERNER RICHARD A | Directior | 2018-10-22 | Option Exercise | 12,500 | 1.50 | 18,750 | 2018-10-24 16:33:11 |
